The present invention relates to the use of amyloid fibrils for providing nutritional minerals to the human body, particularly as a component in a food product, a dietary supplement or in a pharmaceutical product. The invention further provides for new compositions comprising composite materials of amyloid fibrils and nutritional minerals. The invention further relates to the use of such composite materials in the treatment of diseases and disorders and to the fortification of food and dietary supplements with nutritional minerals.

The present invention relates to the use of amyloid fibrils for providing nutritional minerals to the human body, particularly as a component in a food product, a dietary supplement or in a pharmaceutical product. The invention further provides for new compositions comprising composite materials of amyloid fibrils and nutritional minerals. The invention further relates to the use of such composite materials in the treatment of diseases and disorders and to the fortification of food and dietary supplements with nutritional minerals.

The present disclosure relates to human milk compositions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery.

Provided here is a feed supplement composition for animal food products comprising a fish-derived hydrolysate peptide (FHP) and a mannan oligosaccharide (MOS) are provided herein. The combination was found to result in unexpected increases in feed intake, feed conversion and body weight gain when used in an animal feed. Also provided are methods of using an animal feed comprising FHP and MOS to improve poultry agriculture performance.

A nutraceutical dietary supplement formulation for the treatment of joint pain and discomfort may include astaxanthin powder; boswellia serrate gum resin extract; hyaluronic acid; undenatured type II (UC-II) collagen; eggshell membrane collagen powder; turmeric root extract; white willow bark extract; cayenne pepper extract; and Cat's Claw bark powder. The formulation may be formed into capsules for delivery to a user, wherein a therapeutically effective dosage of the formulation may be included in each capsule.

The present invention relates to collagen hydrolysate for use as an active substance in order to delay the ageing of cells in the bodies of humans or animals.

The fields of virology, oncology, and primary care need a drug that can upregulate expression of genes responsible for viral and abnormal cell clearance, such as p53 and those associated with or within the RNA interference (RNAi) process. It is well-known that cellular responses to viral genes and proteins, and indeed that of precancerous or cancerous cells, require the mechanistic efforts via p53 and the RNAi. Without the p53/RNAi activities, viral load and abnormal cell presence may remain or create disease processes and symptoms. The present invention features compositions (e.g., Sarravis® Core) and methods that allow for a decrease in viral and/or cancer cell expression through up regulation of RNAi, p53, and associated cofactors.

A method for producing a mammalian brain protein hydrolysate composition, by providing a mammalian brain protein hydrolysate, adding Zn ions to the mammalian brain protein hydrolysate to form a complex with the Zn ions and the mammalian brain protein hydrolysate, and obtaining the complex with the Zn ions and the mammalian brain protein hydrolysate in a mammalian brain protein hydrolysate composition. A composition with a mammalian brain protein hydrolysate. A nutritional supplement with a mammalian brain protein hydrolysate. A pharmaceutical composition with a mammalian brain protein hydrolysate.

Methods and compositions for providing control over a subject's body, include methods and compositions for enhancing the ability of a subject's body to lose weight, or for inducing weight loss in the subject's body. Such methods and compositions may induce thermogenesis in the adipocytes of a subject's body, enhancing the subject's metabolism, inhibit adipogenesis in adipocytes of the individual, and reduce the subject's cravings for food, the subject's appetite and/or the amount of food consumed by the subject. Such a composition may include African mango (Irvinia gabonensis) seed extract, citrus fruits extract from Citrus aurantium, Citrus sinensis, and/or Citrus paradisi (standardized to 5% synephrine and 80% bioflavonoids), Coleus forskholi root extract, and a source of dihydrocapsiate. The composition may be administered with a protein supplement, such as a whey protein supplement (e.g., a hydrolyzed whey protein supplement).

A problem to be solved by the present invention is to provide a novel material increasing antimicrobial peptide production from epithelial cells and thereby having an infection-preventing effect. The present invention provides a composition for promoting antimicrobial peptide production containing lactic acid bacteria of the genus Lactobacillus as an active ingredient. The present invention also provides a composition for promoting antimicrobial peptide production containing a component derived from a Lactobacillus bacterial cell as an active ingredient. The present invention further provides a composition for promoting antimicrobial peptide production in which the component derived from a bacterial cell is one or more selected from the group consisting of an S-layer protein and a degradation product of the S-layer protein.